维普中文期刊产品整合服务
101篇 您的检索式:作者名="PHILIP PA"
    题名 作者 年代 出处 被引量
1Phase Ⅱ study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer显示文摘Philip PA Mahoney MR Allmer C 2005J Clin Oncol2005,23,66:1
2Emerging Bcl-2 inhibitors for the treatment of cancer 显示文摘Azmi AS Wang Z Philip PA 2011Expert Opin Emerg Drugs2011,16,1:1
3Protein kinase C:A target for therapy in pancreatic cancer显示文摘El-Rayes BF Ali S Philip PA 2008Pancreas2008,36,4:1
4Overexpression of Cu/ Zn superoxide dismutase protects against early diabetic glomerular injury in transgenic mice 显示文摘Craven PA Melhem MF Philips SL 2001Diabetes2001,50,9:1
5Phase Ⅱ study oferlotinib in patients with advanced biliary cancer显示文摘Philip PA Mahoney MR Allmer C 0,,19:1
6Age related alteration of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass,heart rate, contractility and loading condition 显示文摘Kitzman DW Sheikh KH Beere PA Philips JL Higginbotham MB 1991J Am Coll Cardiol1991,18,5:1
7Phase Ⅱ study of gemcitabine and cisplatin in a advanced or metastatic pancreatic cancer显示文摘Philips PA Zalupski M Veitkevicius VK 1999Proc Am Soc Clin Oncol1999,18,:1
8Phase ⅡI study comparing gemcitabine plus cetuximab bersus gemcitabine in patients with advanced pancreatic ademocarcinoma: southwest oneology group-directed intergroup trial 显示文摘PHILIP PA BENEDETTI J CORLESS CL 2010J Clin Oncol2010,28,22:1
9A single institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies显示文摘Vaishampayan UN Ben-Josef E Philip PA 2002Int J Radiat Oncol Biol Phys2002,53,:1
10Phase Ⅱ study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma显示文摘Philip PA Zalupski MM Vaitkevicius VK 2001Cancer2001,92,3:1
11Phase Ⅱ study of erlo- finib in patients with advanced biliary cancer显示文摘Philip PA Mahoney MR Allmer C 2006J Grin Oncol2006,24,19:1
12Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adeno- carcinoma: Southwest Oncology Group-directed inter- group trial S0205显示文摘Philip PA Benedetti J Corless CL 2010J Clin Oncol2010,28,22:1
13Response to dual blockade of epidermal growth factor receptor (EGFR) and eycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor 显示文摘Gadgeel SM Ali S Philip PA 2007Cancer2007,110,:1
14Phase Ⅱstudy of erlotinib (OSI-774)in patients with advanced hepatocellular cancer显示文摘PHILIP PA MAHONEY MR ALLMER C 2005J Clin Oncol2005,23,27:1
15Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase I b and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gerncitabine plus erlotinib (SWOG S0727)显示文摘Philip PA Goldman B Ramanathan RK 2014Cancer2014,120,19:1
16Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2显示文摘Palmer PA Vinke J Philip T 1992Ann Oncol1992,3,6:1
17Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug 显示文摘Philip PA Zonder JA 1999Expert Opin Investig Drags1999,8,12:1
18Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRLinositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate显示文摘Zhang X Hartz PA Philip E 1998J Biol Chem1998,273,:1
19CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy显示文摘Hammad N Heilbrun LK Philip PA 2010Asia Pac J Clin Oncol2010,6,2:1
20Dual blockade of epidermal growth factor receptor (EGFR) and insu- lin-like growth factor receptor-1 (IGF-1R) signaling in metastatic pancreatic cancer: Phase I/randomized phase Ⅱ trial of gemcit- abine, erlotinib, and cixutumumab versus gemcitabine plus erlo- tinib (SWOG-0727) 显示文摘PHILIP PA GOLDMAN BH RAMANATHAN RK 2012J Clin Oncol2012,,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费